RXII Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-1.038|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-9.004M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)||-13788%|
|Dividend Yield (TTM)||0%|
|Payout Ratio (TTM)||Upgrade|
PR Newswire01/05 07:02
PR Newswire12/22 07:02
SA Breaking News12/19 12:45
PR Newswire12/19 07:05
PR Newswire12/17 07:02
|06/02/2014||Misc||Annual General Meeting for RXi Pharmaceuticals Corp|
RXII Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). RXi Pharmaceuticals is down 77.05% over the last year vs S&P 500 Total Return up 14.77%, Galena Biopharma down 69.32%, and Immunogen down 49.34%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for RXII
Portfolio Strategies Featuring RXII
Did RXi Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.rxipharma.com
- HQ Country: United States
- HQ State/Province: Massachusetts
- Incorporation Country: United States
- Incorporation State/Province: Delaware
- Est. Current Fiscal Quarter End: March 31, 2015
- Est. Current Fiscal Year End: December 31, 2015
- Last Fiscal Quarter End: September 30, 2014
- Last Fiscal Year End: December 31, 2013
- Next Earnings Release: N/A
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
RXi Pharmaceuticals Corp is a biotechnology company focused on discovering, developing and commercializing therapies based on its proprietary, next-generation RNA interference platform.
RXII Excel Add-In Codes
- Name: =YCI("RXII","name")
- Description: =YCI("RXII","description")
- Sector: =YCI("RXII","sector")
- Industry: =YCI("RXII","industry")
- Est. Current Fiscal Year End: =YCI("RXII","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.